|
Powered by Cell Signaling Technology |
Site Information |
---|
NRHsLPFsLPSQMEP SwissProt Entrez-Gene |
Blast this site against: NCBI SwissProt PDB |
Site Group ID: 10288600 |
In vivo Characterization | |
---|---|
Methods used to characterize site in vivo: | |
Relevant cell line - cell type - tissue: |
Downstream Regulation | |
---|---|
Effects of modification on CBL: | |
Induce interaction with: |
References | |
---|---|
Guo A (2011) CST Curation Set: 12455; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: (K/R)Xp[ST](I/L/V)
Curated Info |
|
Guo A (2011) CST Curation Set: 12456; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: (K/R)Xp[ST](I/L/V)
Curated Info |
|
Pedraza-Alva G, et al. (2001) Regulation of Cbl molecular interactions by the co-receptor molecule CD43 in human T cells. J Biol Chem 276, 729-37
11024037 Curated Info |